---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-062424"
form_type: "8-K"
ticker: "VREOF"
cik: "0001771706"
company_name: "Vireo Growth Inc."
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T19:57:44.270458+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Goodness Growth Holdings Q1 revenue $19.1M (+22% YoY); positive operating income of $0.4M

## Summary
- Q1 revenue $19.1M (+22.1% YoY); gross margin 49.9% vs 15.9%; SG&A down 22.6%.
- Operating income of $0.4M vs loss of $7.8M in prior year; EBITDA $1.4M.
- Closed $2M initial tranche of $10M convertible debt; 12% interest; conversion at $0.145; warrants for 6.25M shares.
- Credit facility amendment extends maturity to Apr 2024, removes amortization; up to 15M shares to lenders.
- Management reorganization: Josh Rosen interim CEO, Amber Shimpa as CEO of Vireo Health MN, founder becomes Exec Chairman.

## SEC filing metadata
- accession: 0001104659-23-062424
- form_type: 8-K
- ticker: VREOF
- cik: 0001771706
- company_name: Vireo Growth Inc.
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/0001104659-23-062424-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/tm2316190d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-062424
- JSON: https://secwatch.observer/filing/0001104659-23-062424.json
- Plain text: https://secwatch.observer/filing/0001104659-23-062424.txt

## Key facts
- Earnings Releases
  Vireo Growth Inc. reported first quarter ended March 31, 2023 results: revenue $ 19.1.
  - Period: first quarter ended March 31, 2023
  - Revenue: $ 19.1
  - Result: reported results
  source text: referenced in this press are denominated in U.S. dollars. Summary of Key Financial Metrics Three Months Ended US $ in millions March 31, 2023 2022 Variance GAAP Revenue $ 19.1 $ 15.6 22.1 % Revenue (excluding discontinued operations) $ 19.1 $ 14.6 30.5 % GAAP Gross Profit $ 9.5 $ 2.5 280.0 % Gross Profit Margin 49.9 % 15.9 % 3,400 bps SG&A Expenses
  evidence_url: https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/0001104659-23-062424-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.